Seasonal allergic rhinitis — the medical name for what most people call "seasonal allergies" or "hay fever" — is an IgE-mediated inflammatory response of the nasal mucosa to airborne allergens that cycle through the year with the pollen calendar. In the Tampa Bay region, the pattern is unusual: our warm climate, near-constant humidity, and long growing season mean that pollen pressure is essentially year-round rather than concentrated into a single spring "allergy season." Patients moving to St. Petersburg from cooler climates often discover that the seasonal rhythms they relied on for symptom relief no longer apply.
This page covers what triggers symptoms, why Gulf Coast patients tend to have a tougher experience than the U.S. average, how to distinguish allergic rhinitis from infectious sinusitis and non-allergic rhinitis (which need different treatment), and the stepwise medical strategy we use at Zimmer Medical Group. For closely related issues, see our overviews of hay fever, non-allergic rhinitis, sinusitis, and postnasal drip syndrome.
Why "seasonal" is misleading in Florida
In northern states, oak, birch, and grass pollen rise in spring, ragweed peaks in late summer and fall, and winter is largely free of outdoor allergens. In the Tampa Bay region, the calendar collapses:
- December–April: heavy tree pollen, especially oak, with bald cypress, juniper, and pine layered on top. The famous yellow oak-pollen "snowfall" coats cars and pool decks across Pinellas County from late February through April.
- April–October: grass pollen, dominated by Bahia and Bermuda grass, with significant contributions from lawn maintenance year-round.
- August–November: ragweed and other weed pollens.
- Year-round: outdoor mold spores driven by humidity, indoor mold in coastal homes, and dust mites that thrive at our ambient humidity levels.
The practical implication is that Tampa Bay patients with seasonal allergic rhinitis rarely get the multi-month symptom-free intervals available to northern allergy sufferers, and our threshold for stepping up to prescription therapy or immunotherapy is correspondingly lower.
What causes the symptoms biologically
The first time a susceptible person inhales a pollen they are sensitized to, dendritic cells in the nasal mucosa present allergen fragments to T-helper cells, which drive B cells to produce allergen-specific IgE. That IgE binds to mast cells lining the airway. On subsequent exposures, the allergen crosslinks IgE on mast cells, triggering immediate release of histamine, leukotrienes, prostaglandins, and tryptase. The result is the early-phase reaction: sneezing within minutes, clear rhinorrhea, nasal itching, and conjunctival inflammation.
A late-phase reaction follows four to twelve hours later, dominated by eosinophil infiltration and persistent congestion. This biphasic pattern explains why patients often feel worst in the evening even though they encountered pollen in the morning, and why intranasal corticosteroids (which suppress the late phase) outperform oral antihistamines (which mostly blunt the early phase) in most head-to-head trials.
Symptoms and what to watch for
The classic constellation is the "allergic salute" — repeated upward swipes of the nose — plus sneezing, clear watery rhinorrhea, nasal congestion, itchy palate and eyes, post-nasal drip, and fatigue. The fatigue is real and often underestimated: chronic nasal obstruction degrades sleep architecture, particularly in patients with even mild underlying obstructive sleep apnea.
Symptoms that suggest something other than uncomplicated allergic rhinitis and warrant a visit include:
- Unilateral symptoms (one-sided congestion or discharge), which can indicate a structural problem or nasal polyp
- Purulent yellow-green discharge persisting more than ten days, or fever and facial pain — consider bacterial sinusitis
- Loss of smell (anosmia) lasting more than a few weeks — can signal nasal polyposis
- Bloody discharge or recurrent epistaxis
- New asthma symptoms or worsening control in a patient with known asthma
- Year-round symptoms in a person who recently moved to a new home (consider indoor mold, dust mite, or pet sensitization)
Diagnosis
For most patients the diagnosis is clinical: a coherent seasonal pattern, characteristic symptoms, and a response to empiric treatment. Allergy testing — either skin prick testing or allergen-specific IgE blood testing — becomes valuable when:
- Symptoms are severe or year-round and the trigger is not obvious
- The patient is considering immunotherapy (allergy shots or sublingual tablets)
- Avoidance measures depend on identifying a specific allergen (e.g., a particular pet, a specific mold, or a single dominant pollen)
Skin prick testing produces results within fifteen minutes and remains the gold standard for sensitivity. Blood IgE testing is preferable in patients on antihistamines (which suppress skin reactivity for up to a week), in those with extensive eczema, or when there is a history of severe anaphylaxis.
Treatment: a stepwise approach
1. Avoidance and environmental control
Closed windows with the air conditioner running during peak pollen days, a daily shower and clothing change after extended outdoor time, and a HEPA filter in the bedroom are the cheapest and safest interventions. For Florida patients with mold sensitivity, fixing leaks, running a dehumidifier in damp rooms, and keeping indoor humidity below fifty percent makes a measurable difference. Avoid drying laundry outdoors during high pollen periods, and shower before bed rather than in the morning to keep pollen out of the pillow.
2. Intranasal corticosteroids (first-line for most patients)
For symptoms more than a few days per week, an intranasal corticosteroid is the most effective single agent we have. Fluticasone nasal spray (Flonase) and triamcinolone (Nasacort) are available over the counter; mometasone (Nasonex) and budesonide (Rhinocort) are also widely used. Start one to two weeks before your typical symptom onset for best effect, and use daily through the season — not just when symptomatic. The most common reason for failure is sporadic use and incorrect spray technique (aim the spray toward the outer wall of the nostril, away from the septum).
3. Antihistamines
Second-generation oral antihistamines — loratadine (Claritin), cetirizine (Zyrtec), fexofenadine (Allegra) — relieve sneezing, itch, and rhinorrhea but are less effective for congestion. They can be added to an intranasal corticosteroid for incomplete responders. First-generation antihistamines like diphenhydramine cause sedation, impair driving performance, and are not appropriate for daily allergy use. Intranasal antihistamines such as azelastine work quickly and are useful as add-on therapy or for patients who prefer not to use oral medications.
4. Leukotriene receptor antagonists
Oral montelukast (Singulair) is useful for patients with overlapping asthma and allergic rhinitis. The FDA has issued a boxed warning regarding neuropsychiatric effects, including mood changes and rare suicidality, so we typically reserve montelukast for patients who clearly benefit and discuss the warning explicitly before prescribing.
5. Decongestants
Oral pseudoephedrine and topical oxymetazoline give rapid relief of congestion but are not appropriate for daily long-term use. Topical decongestant sprays cause rebound congestion (rhinitis medicamentosa) after roughly three days of regular use. Patients with cardiovascular disease, uncontrolled blood pressure, or significant prostate symptoms should avoid systemic decongestants.
6. Allergen immunotherapy
For patients with confirmed sensitization, persistent symptoms despite optimized pharmacotherapy, or a desire to reduce long-term medication use, immunotherapy is the only treatment that modifies the underlying disease. Subcutaneous immunotherapy (allergy shots) requires weekly injections during a build-up phase followed by monthly maintenance for three to five years. Sublingual immunotherapy tablets are FDA-approved for grass and ragweed in the United States and offer a home-based alternative for selected patients. Either option is referred to an allergist; primary care manages the rest of the treatment plan.
Special situations
Pregnancy
Intranasal corticosteroids (especially budesonide), saline irrigation, and loratadine or cetirizine are generally considered safe in pregnancy. Pseudoephedrine and montelukast deserve case-by-case discussion. We co-manage with the patient's OB whenever decisions are not clear-cut.
Children
Most second-generation antihistamines and several intranasal corticosteroids are approved in pediatric formulations. Behavior changes, school performance, and sleep are useful outcome measures — children rarely volunteer that their allergies are bothering them, but the secondary effects are often striking.
Patients with asthma
Untreated allergic rhinitis worsens asthma control. Treating the upper airway is part of treating the lower airway, and our usual practice when adjusting asthma regimens is to make sure the nose is being addressed at the same time.
When to see a primary care physician
If over-the-counter therapy isn't controlling symptoms, if you have year-round symptoms, if you have asthma or recurrent sinusitis, or if you're considering immunotherapy, an in-person evaluation makes sense. We can sort out whether you have allergic rhinitis, non-allergic rhinitis, sinusitis, or a structural problem, and tailor a regimen that doesn't depend on guessing.
To learn more about the climate factors that shape allergy patterns here, see our St. Petersburg-focused articles on Local Vitals. To schedule an appointment, contact us or use our online scheduling page.